Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia

View source ↗

Summary

A study evaluating biomarkers sFlt-1/PlGF ratio, OPG, and sEng for the diagnosis and treatment evaluation of preeclampsia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ammar Jassim Abed | Conditions: Preeclampsia, Gestational Hypertension | Status: RECRUITING